Status:
COMPLETED
Testosterone Implants and the Incidence of Breast Cancer
Lead Sponsor:
Millennium Wellness LLC
Conditions:
Breast Cancer
Eligibility:
FEMALE
24-92 years
Brief Summary
This current chart review study was designed to investigate the incidence of breast cancer in women treated with subcutaneous testosterone therapy for symptoms of hormone deficiency.
Detailed Description
A prior ten-year prospective, observational, study was initially approved in March of 2008 by the IRB board through the Atrium Medical Center, Premier Health Partners in Middletown, Ohio 45005 and reg...
Eligibility Criteria
Inclusion
- Female patients treated between March 2008 - March 2013
- Women who received at least two testosterone pellet insertion procedures
- Women previously accrued to the prospective cohort study
Exclusion
- Pre-existing breast cancer
- Women who received a single testosterone pellet insertion
Key Trial Info
Start Date :
March 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2018
Estimated Enrollment :
1268 Patients enrolled
Trial Details
Trial ID
NCT03768258
Start Date
March 1 2008
End Date
December 1 2018
Last Update
September 5 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.